Finanzen von Alcon AG (ALC)ALCAlcon AG

Alcon AG (ALC) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Consumables, accounting for 29.2% of total sales, equivalent to $825.00M. Other significant revenue streams include Contact lenses and Ocular health. Understanding this composition is critical for investors evaluating how ALC navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, Alcon AG maintains a gross margin of 60.50%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 1.56%, while the net margin is 0.00%. These profitability ratios, combined with a Return on Equity (ROE) of 2.94%, provide a clear picture of how effectively ALC converts its operational activities into shareholder value.

In the context of the broader market, ALC competes directly with industry leaders such as DXCM and WST. With a market capitalization of $32.60B, it holds a leading position in the sector. When comparing efficiency, ALC's gross margin of 60.50% stands against DXCM's 63.44% and WST's 37.74%. Such benchmarking helps identify whether Alcon AG is trading at a premium or discount relative to its financial performance.

Alcon's gross margin is strong at 60.50%, and its current ratio of 2.09 indicates good liquidity. However, the net income for Q2 2026 was $0, which raises concerns about profitability.